NNH

NOR-N-OMEGA-HYDROXY-L-ARGININE

Find entries where: NNH

is present as a standalone ligand in 5 entries

Find related ligands:

Chemical Component Summary
Name	NOR-N-OMEGA-HYDROXY-L-ARGININE
Identifiers	(2S)-2-amino-4-[(N-hydroxycarbamimidoyl)amino]butanoic acid
Formula	C₅ H₁₂ N₄ O₃
Molecular Weight	176.174
Type	L-PEPTIDE LINKING
Isomeric SMILES	[H]/N=C(/NCC[C@@H](C(=O)O)N)\NO
InChI	InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-8-5(7)9-12/h3,12H,1-2,6H2,(H,10,11)(H3,7,8,9)/t3-/m0/s1
InChIKey	KOBHCUDVWOTEKO-VKHMYHEASA-N

Chemical Details
Formal Charge	0
Atom Count	24
Chiral Atom Count	1
Bond Count	23
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB02381
Name	nor-NOHA
Groups	investigational
Description	N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
Synonyms	Nomega-Hydroxy-nor-L-arginine N-hydroxy-nor-arginine N-hydroxy-nor-L-arginine nor-NOHA (2S)-2-amino-4-(((hydroxyamino)iminomethyl)amino)butanoic acid
CAS number	189302-40-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Arginase-1	MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDY...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682